Hypertension Diagnostics HDII Stock
Hypertension Diagnostics Price Chart
Hypertension Diagnostics HDII Financial and Trading Overview
Hypertension Diagnostics stock price | 0.0002 USD |
Previous Close | 0.0012 USD |
Open | 0.0012 USD |
Bid | N/A x N/A |
Ask | N/A x N/A |
Day's Range | 0.0012 - 0.0012 USD |
52 Week Range | 0.001 - 0.0098 USD |
Volume | 1.5K USD |
Avg. Volume | 51.68K USD |
Market Cap | 654.86K USD |
Beta (5Y Monthly) | -1.12183 |
PE Ratio (TTM) | N/A |
EPS (TTM) | 0 USD |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
HDII Valuation Measures
Enterprise Value | 1.47M USD |
Trailing P/E | N/A |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 0.17269006 |
Price/Book (mrq) | N/A |
Enterprise Value/Revenue | 0.387 |
Enterprise Value/EBITDA | 39.981 |
Trading Information
Hypertension Diagnostics Stock Price History
Beta (5Y Monthly) | -1.12183 |
52-Week Change | -68.42% |
S&P500 52-Week Change | 20.43% |
52 Week High | 0.0098 USD |
52 Week Low | 0.001 USD |
50-Day Moving Average | 0.00242 USD |
200-Day Moving Average | 0.002994 USD |
HDII Share Statistics
Avg. Volume (3 month) | 51.68K USD |
Avg. Daily Volume (10-Days) | 101.63K USD |
Shares Outstanding | 52.39M |
Float | N/A |
Short Ratio | 0 |
% Held by Insiders | 0% |
% Held by Institutions | 0% |
Shares Short | 0 |
Short % of Float | N/A |
Short % of Shares Outstanding | 0% |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2018 |
Most Recent Quarter (mrq) | March 31, 2013 |
Next Fiscal Year End | December 31, 2019 |
Profitability
Profit Margin | -3.30% |
Operating Margin (ttm) | 0.018% |
Gross Margin | 25.16% |
EBITDA Margin | 0.96% |
Management Effectiveness
Return on Assets (ttm) | 0.032% |
Return on Equity (ttm) | N/A |
Income Statement
Revenue (ttm) | 3.79M USD |
Revenue Per Share (ttm) | 0.07 USD |
Quarterly Revenue Growth (yoy) | -100.00000000000000000000000000000000% |
Gross Profit (ttm) | 954.47K USD |
EBITDA | 36.71K USD |
Net Income Avi to Common (ttm) | -125388 USD |
Diluted EPS (ttm) | 0 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 5.66K USD |
Total Cash Per Share (mrq) | 0 USD |
Total Debt (mrq) | 1.3M USD |
Total Debt/Equity (mrq) | N/A |
Current Ratio (mrq) | 0.525 |
Book Value Per Share (mrq) | -0.091 |
Cash Flow Statement
Operating Cash Flow (ttm) | -389278 USD |
Levered Free Cash Flow (ttm) | -432000 USD |
Profile of Hypertension Diagnostics
Country | United States |
State | ON |
City | Richmond Hill |
Address | 550 Highway 7 East |
ZIP | L4B 3Z4 |
Phone | 404-449-6151 |
Website | https://www.hypertensiondiagnostics.com |
Industry | Shell Companies |
Sector(s) | Financial Services |
Full Time Employees | N/A |
Hypertension Diagnostics, Inc. designs, develops, manufactures, and markets proprietary noninvasive medical devices that detect subtle changes in the elasticity of arteries in the United States and internationally. It offers CVProfilor, which allows a physician to non-invasively assess the elasticity of small and large arteries, of which small artery elasticity is the earliest and sensitive marker of cardiovascular disease. The company offers CVProfilor DO-2020, which provides a patient's arterial elasticity indices used in the assessment for underlying vascular disease; CVProfilor MD-3000 that offers a sensitive and specific guide to the presence of blood vessel disease; and HD/PulseWave CR-2000 research cardiovascular profiling system, which provides researchers and scientists with a non-invasive means to assess arterial elasticity in support of human research in various areas. Its products collect 30 seconds of blood pressure waveform data, perform an analysis of the digitized blood pressure waveforms, and generate a CVProfile report that contains information on blood pressure, heart rate, pulse pressure, body surface area, body mass index, and C1-large and C2-small artery elasticity indices. The company sells its products to primary care physicians, cardiologists, health care professionals, trained medical personnel, research investigators at academic medical research centers, government institutes, cardiovascular specialists, and pharmaceutical firms. It markets its products through a representative organization in the United States. Hypertension Diagnostics, Inc. was founded in 1988 and is based in Richmond Hill, Canada.
Q&A For Hypertension Diagnostics Stock
What is a current HDII stock price?
Hypertension Diagnostics HDII stock price today per share is 0.0002 USD.
How to purchase Hypertension Diagnostics stock?
You can buy HDII shares on the Other OTC exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Hypertension Diagnostics?
The stock symbol or ticker of Hypertension Diagnostics is HDII.
Which industry does the Hypertension Diagnostics company belong to?
The Hypertension Diagnostics industry is Shell Companies.
How many shares does Hypertension Diagnostics have in circulation?
The max supply of Hypertension Diagnostics shares is 284.78M.
What is Hypertension Diagnostics Price to Earnings Ratio (PE Ratio)?
Hypertension Diagnostics PE Ratio is now.
What was Hypertension Diagnostics earnings per share over the trailing 12 months (TTM)?
Hypertension Diagnostics EPS is 0 USD over the trailing 12 months.
Which sector does the Hypertension Diagnostics company belong to?
The Hypertension Diagnostics sector is Financial Services.